Acute mesenteric venous thrombosis in a pregnant woman at 35 weeks of gestation: a case report and review of the literature

Table 1 Incidence of MVT during pregnancy

Case	Ref.	Year	Additional risk	Maternal age	Gestational age (week)	Intestinal resection	Anti-coagulation	Pregnancy outcome
1	Sönmezer, et al. [12]	2004	factor V Leiden gene mutation	32	27	No	Yes	Vaginal delivery at 39 weeks
2	Atakan, et al. [13]	2009	Protein S deficiency	25	20	Yes	Yes	Maternal death
3	Liu, et al. [14]	2014	Protein S deficiency	38	7	Yes	Yes	Vaginal delivery of a normal baby
4	García-Botella, et al. [15]	2016	Antithrombin deficiency	29	7	Yes	Yes	Vaginal delivery at 36 weeks gestation
5	Hirata, et al. [9]	2017	Oral estrogen associated with IVF-ET	34	7	Yes	Yes	Elective abortion
6	Friedman, et al., Graubard and Friedman [16, 17]	1984, 1987	Oral contraceptive	30	14	Yes	Yes	ND
7	Shui, et al. [18]	2011	Mid-gut volvulus	25	35	No	Yes	Cesarean delivery at 35 weeks gestation
8	Giannos, et al. [19]	2017	Mesenteric cyst	27	10	Yes	Yes	Incomplete abortion
9	Zamani, et al. [20]	2009	CMV infection	22	31	Yes	Yes	Fetal death
10	Chan, et al. [21]	2009	Chronic idiopathic MVT	26	7	Yes	Yes	Elective abortion
11	Engelhardt and Kerstein [11]	1989	Idiopathic	32	10	Yes	Yes	Vaginal delivery of a normal baby
12	Foo, et al. [22]	1996	Idiopathic	27	6	No	Yes	Elective abortion
13	Fouad, et al. [10]	2001	Idiopathic	35	28	Yes	Yes	Vaginal delivery at 40 weeks gestation
14	Lin, et al. [23]	2011	Idiopathic	31	34	Yes	Yes	Cesarean delivery at 34 weeks gestation
15	Current report	2018	Idiopathic	26	35	Yes	Yes	Fetal death

CMV, cytomegalovirus; IVF-ET, in vitro fertilization and embryo transfer; MVT, mesenteric venous thrombosis; ND, not described

ISSN: 1471-2393